Hallek, M., & Hensel, M. (2010). Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, open-label, phase 3 trial. The lancet, 376(9747), . https://doi.org/10.1016/S0140-6736(10)61381-5
Chicago-Zitierstil (17. Ausg.)Hallek, Michael, und Manfred Hensel. "Addition of Rituximab to Fludarabine and Cyclophosphamide in Patients with Chronic Lymphocytic Leukaemia: A Randomised, Open-label, Phase 3 Trial." The Lancet 376, no. 9747 (2010). https://doi.org/10.1016/S0140-6736(10)61381-5.
MLA-Zitierstil (9. Ausg.)Hallek, Michael, und Manfred Hensel. "Addition of Rituximab to Fludarabine and Cyclophosphamide in Patients with Chronic Lymphocytic Leukaemia: A Randomised, Open-label, Phase 3 Trial." The Lancet, vol. 376, no. 9747, 2010, https://doi.org/10.1016/S0140-6736(10)61381-5.